Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
enzalutamide (xtandi) (1 trial)
oric-101 (4 trials)
oric-114 (2 trials)
oric-533 (1 trial)
oric-944 (1 trial)
paclitaxel (taxol) (1 trial)
Prostatic Neoplasms (Phase 1)
Trials (8 total)
Trial APIs (6 total)